Mediq Eesti OÜ

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	22.06.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	20.06.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	26.06.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	12.09.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	18.08.2022	Valid	PDF
2021	01.01.2021 – 31.12.2021	07.06.2022	Expired	PDF
2020	01.01.2020 – 31.12.2020	01.06.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	01.06.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	18.06.2019	Valid	PDF
2017	01.01.2017 – 31.12.2017	22.06.2018	Valid	PDF
2016	01.01.2016 – 31.12.2016	22.06.2017	Valid	PDF
2015	01.01.2015 – 31.12.2015	21.06.2016	Valid	PDF
2014	01.01.2014 – 31.12.2014	26.06.2015	Valid	PDF
2013	01.01.2013 – 31.12.2013	02.04.2014	Valid	PDF
2012	01.01.2012 – 31.12.2012	24.05.2013	Valid	PDF
2011	01.01.2011 – 31.12.2011	19.11.2012	Valid	PDF
2011	01.01.2011 – 31.12.2011	11.05.2012	Expired	PDF
2010	26.05.2010 – 31.12.2010	29.04.2011	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 19.10.2026.

Delayed declarations

Intra-Community supply report

22.12.2025

29.12.2025

7 d overdue

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions–Official announcements1 TTJA decisions–Real estate–.ee domains2 Licenses–Regulations26 Public transactions35,3k Grants–State aid2 Public procurement2547 Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	745 623 €	221 549 €	7,15 M €−4,7%	47
2026 Q2	772 541 €	234 283 €	7,50 M €+1,9%	48
2026 Q1	713 936 €	214 375 €	7,36 M €−5,0%	46
Total 2026:	2,23 M €	670 207 €	22,0 M €
2025 Q4	780 512 €	220 312 €	7,75 M €+11,4%	47
2025 Q3	701 486 €	219 458 €	6,96 M €−3,8%	45
2025 Q2	749 092 €	258 471 €	7,23 M €−5,7%	45
2025 Q1	683 014 €	212 133 €	7,67 M €+6,6%	46
Total 2025:	2,91 M €	910 374 €	29,6 M €
2024 Q4	701 642 €	199 857 €	7,20 M €+14,4%	45
2024 Q3	681 429 €	206 555 €	6,29 M €−7,5%	47
2024 Q2	681 401 €	212 252 €	6,80 M €−3,2%	46
2024 Q1	689 438 €	208 928 €	7,02 M €+5,1%	48
Total 2024:	2,75 M €	827 592 €	27,3 M €
2023 Q4	684 939 €	193 809 €	6,68 M €+21,2%	48
2023 Q3	505 079 €	198 820 €	5,52 M €−21,3%	47
2023 Q2	668 156 €	222 224 €	7,01 M €+1,6%	47
2023 Q1	604 676 €	219 490 €	6,90 M €+5,5%	47
Total 2023:	2,46 M €	834 343 €	26,1 M €
2022 Q4	659 378 €	178 830 €	6,54 M €+5,9%	47
2022 Q3	595 523 €	192 769 €	6,18 M €−21,7%	49
2022 Q2	636 387 €	188 486 €	7,89 M €+25,2%	49
2022 Q1	661 304 €	223 060 €	6,30 M €−5,6%	49
Total 2022:	2,55 M €	783 145 €	26,9 M €
2021 Q4	641 636,34 €	166 801,33 €	6,68 M €−6,2%	50
2021 Q3	579 825,74 €	178 455,86 €	7,12 M €−9,9%	47
2021 Q2	584 848,02 €	187 570,20 €	7,90 M €+36,3%	49
2021 Q1	528 475,41 €	211 436,40 €	5,80 M €−13,3%	47
Total 2021:	2,33 M €	744 263,79 €	27,5 M €
2020 Q4	566 830,76 €	156 259,28 €	6,68 M €+28,0%	50
2020 Q3	504 431,96 €	162 168,32 €	5,22 M €−13,2%	50
2020 Q2	507 622,44 €	179 179,76 €	6,01 M €+5,8%	51
2020 Q1	504 824 €	183 456 €	5,68 M €+3,1%	53
Total 2020:	2,08 M €	681 063,36 €	23,6 M €
2019 Q4	478 114 €	145 927 €	5,51 M €+15,0%	50
2019 Q3	457 136 €	149 040 €	4,79 M €−13,9%	49
2019 Q2	517 687 €	166 116 €	5,56 M €+14,3%	45
2019 Q1	440 129 €	136 378 €	4,87 M €−2,2%	45
Total 2019:	1,89 M €	597 461 €	20,7 M €
2018 Q4	411 275 €	131 953 €	4,98 M €+14,8%	46
2018 Q3	515 251 €	138 280 €	4,34 M €−9,3%	46
2018 Q2	406 463 €	139 592 €	4,78 M €−4,6%	46
2018 Q1	417 927 €	136 520 €	5,01 M €+24,8%	45
Total 2018:	1,75 M €	546 345 €	19,1 M €
2017 Q4	388 710 €	119 340 €	4,01 M €−0,3%	46
2017 Q3	334 216 €	123 631 €	4,03 M €−5,9%	46
2017 Q2	330 467 €	134 268 €	4,28 M €+4,1%	46
2017 Q1	384 876 €	120 281 €	4,11 M €+74,5%	45
Total 2017:	1,44 M €	497 520 €	16,4 M €
2016 Q4	347 400 €	109 711 €	2,36 M €−7,9%	43
2016 Q3	302 565 €	119 085 €	2,56 M €−10,7%	43
2016 Q2	386 716 €	133 320 €	2,86 M €+17,4%	43
2016 Q1	308 977 €	113 578 €	2,44 M €−3,3%	43
Total 2016:	1,35 M €	475 694 €	10,2 M €
2015 Q4	359 206 €	109 926 €	2,52 M €−3,5%	44
2015 Q3	407 982 €	113 911 €	2,61 M €−1,5%	44
2015 Q2	335 544 €	115 646 €	2,65 M €+6,0%	44
2015 Q1	328 392 €	109 069 €	2,50 M €	44
Total 2015:	1,43 M €	448 552 €	10,3 M €

Revenue by industry

	2023	2024	2025
Wholesale of medical devices, surgical instruments and orthopaedic appliances	16 510 000 €	16 462 342 €	17 827 822 €
Operation of warehousing and storage facilities	75 144 €	169 209 €

Tax debts

No tax debt found

No tax debt as of 19.10.2026

Representatives

	Personal ID code
Saija Heini Maria Kotkas	-	16.08.1976 (50)	Board member	22.04.2025	-
Thorbjorn Hjarndal	-	03.05.1971 (55)	Board member	22.04.2025	-
Priit Paiste	37011XXXXXX	08.11.1970 (55)	Board member	06.06.2024	-

12 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
Mediq International B.V.	30107XXX	-	Shareholder	2 556 EUR	100,00%	Sole ownership	02.09.2023	-

12 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Other persons

	Personal ID code
KPMG Baltics OÜ	10096082	22.11.1996 (29)	Audit firm	26.05.2010	-
Mediq International B.V.	30107XXX	-	Founder	25.05.2010	-

12 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Priit Paiste	37011XXXXXX	08.11.1970 (55)	Member of higher governing body (board or supervisory board)	06.02.2026	-
Saija Heini Maria Kotkas	-	16.08.1976 (50)	Member of higher governing body (board or supervisory board)	06.02.2026	-
Thorbjorn Hjarndal	-	03.05.1971 (55)	Member of higher governing body (board or supervisory board)	06.02.2026	-

12 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

1 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

2026 Q3

Turnover

Amount: 7 148 548 €
Monthly average: 2 382 849 €
Per employee: 50 699 €
Equity ratio: 93 225,72%

Labour taxes

Turnover ratio: 3,10%
Tax ratio: 29,71%
Monthly average: 73 850 €
Per employee: 1 555 €

State taxes

Monthly average: 248 541 €
Turnover ratio: 10,43%

Estimated salary

Gross salary: 2 844 €
Net salary: 2 293 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	4 721 663 €−7,7%	5 113 730 €+12,8%	4 535 084 €+3,1%	4 398 981 €+4,7%	4 203 087 €+8,7%	3 868 445 €+18,2%	3 273 649 €
Non-current assets	119 991 €−21,9%	153 733 €−40,5%	258 208 €−29,3%	365 182 €−7,3%	393 738 €+56,9%	250 889 €−1,8%	255 602 €
Total assets	4 841 654 €−8,1%	5 267 463 €+9,9%	4 793 292 €+0,6%	4 764 163 €+3,6%	4 596 825 €+11,6%	4 119 334 €+16,7%	3 529 251 €
Short-term liabilities	2 139 113 €−18,0%	2 607 458 €+16,1%	2 246 651 €+4,3%	2 154 532 €	2 154 171 €+17,5%	1 832 946 €+12,0%	1 636 501 €
Long-term liabilities	-	-	-	-	200 000 €	-	-
Total liabilities	2 139 113 €−18,0%	2 607 458 €+16,1%	2 246 651 €+4,3%	2 154 532 €−8,5%	2 354 171 €+28,4%	1 832 946 €+12,0%	1 636 501 €
Share or stock capital	-	-	-	-	-	-	-
Retained earnings	1 660 005 €+23,3%	1 346 641 €−4,5%	1 409 631 €+35,2%	1 042 654 €+5,7%	986 388 €+24,4%	792 750 €+49,8%	529 291 €
Net profit	42 536 €−86,4%	313 364 €+129%	137 010 €−75,8%	566 977 €+121%	256 266 €−48,1%	493 638 €+35,8%	363 459 €
Equity	2 702 541 €+1,6%	2 660 005 €+4,5%	2 546 641 €−2,4%	2 609 631 €+16,4%	2 242 654 €−1,9%	2 286 388 €+20,8%	1 892 750 €
Turnover	17 827 822 €+7,2%	16 631 551 €+0,3%	16 585 144 €−3,6%	17 206 596 €−1,5%	17 470 480 €+14,1%	15 312 891 €+14,9%	13 326 029 €
Profit margin	0,2%	1,9%	0,8%	3,3%	1,5%	3,2%	2,7%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	758 735 €	427 443 €
Liquidity
Current ratio	2,0	2,0
Quick ratio	1,0	0,9
Cash ratio	0,4	0,5
Efficiency
Days sales outstanding (dso)	22,6	20,0
Asset turnover	3,7	4,0
Structure
Debt ratio	0,5	0,5
Profitability
Operating margin	3,6%	1,8%
Net profit margin	3,3%	1,5%
Return on assets (roa)	12,1%	5,9%
Return on equity (roe)	21,7%	11,4%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations


Ä 10144258 / 20	22.04.2025	Entry – Amendment entry	-	Entered into force22.04.2025
Ä 10144258 / M6	07.04.2025	Order to remedy deficiencies – Amendment entry	23.04.2025	Deficiencies remedied22.04.2025
Ä 10144258 / 19	22.09.2024	Entry – Amendment entry	-	Entered into force22.09.2024
Ä 10144258 / 18	06.06.2024	Entry – Amendment entry	-	Entered into force06.06.2024
Ä 10144258 / 17	19.12.2023	Entry – Amendment entry	-	Entered into force19.12.2023

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions

No court decisions found

The company has no court decisions

Official announcements


Notice of company merger	12.10.2021	PDF

Public transactions


30.09.2026	Sihtasutus Pärnu Haigla	765,45 €Received	OPERATING EXPENSESGeneral hospital services
30.09.2026	Sihtasutus Pärnu Haigla	520,80 €Received	OPERATING EXPENSESGeneral hospital services
30.09.2026	Sihtasutus Pärnu Haigla	512,54 €Received	OPERATING EXPENSESGeneral hospital services
30.09.2026	Sihtasutus Pärnu Haigla	156,86 €Received	OPERATING EXPENSESGeneral hospital services
30.09.2026	Tallinna Loomaaed	194,51 €Received	OPERATING EXPENSESZoo

Funded projects

No funded projects found

The company has no projects funded by EU or foreign grants

State aid


01.07.2025	Eesti TöötukassaAid measure 231580	Palgatoetus VTA › Palgatoetus VTAGrant	5 316 €	231580/2600295
01.04.2020	Tallinna LinnakantseleiAid measure 20912	KOMISJONI TEATIS Riigiabi ajutine raamistik majanduse toetamiseks praeguse COVID-19 puhangu kontekstis › Komisjoni teatise jaotis 3.1 "Otsetoetuste, tagasimakstvate ettemaksete või maksusoodustustena antav abi"Grant	7,54 €	20912/2000566

Public procurement contracts


13.10.2026End 12.10.2029	Reference number 312128 · Raamleping_Mediq Eesti OÜ	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	37 700 €	Concluded
12.10.2026End 11.10.2029	Reference number 314301 · Raamleping_Mediq Eesti OÜ_314301_Kanüüliplaastrid	Sihtasutus Tallinna LastehaiglaContracting authority	18 600 €	Concluded
06.10.2026End 05.10.2027	Reference number 313049 · Hankeleping (osad 1 ja 8)	Tallinna KiirabiContracting authority	2 880,24 €	Concluded
06.10.2026End 05.10.2027	Reference number 313049 · Hankeleping (osad 1 ja 8)	Tallinna KiirabiContracting authority	2 880,24 €	Concluded
06.10.2026End 05.10.2027	Reference number 313608 · Hankeleping (osa5)	Tallinna KiirabiContracting authority	515 €	Concluded

.ee domains


mediq24.ee	Active	22.12.2014	23.12.2026
mediq.ee	Active	04.07.2010	15.09.2027

2 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.